Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines

J Steroid Biochem Mol Biol. 1995 Dec;55(3-4):439-44. doi: 10.1016/0960-0760(95)00216-2.

Abstract

Two classes of progestagens, e.g. pregnane [Org 2058, progesterone (PROG), R5020, medroxyprogesterone acetate (MPA)] and 19-nortestosterone derived progestagens [norethisterone (NE), levonorgestrel (LNG), 3-ketodesogestrel (KDG), gestodene (GES), Org 30659] were studied for their effect on cell growth of two human breast tumor T47D cell lines of different origin, i.e. from ATCC (A) and Sutherland (S) et al. [Sutherland et al., Cancer Res. 48 (1988) 5084-5091]. The effect of estradiol (E2) and progestagens alone as well as the combined effect of E2 (10(-10) M) and progestagens were investigated at several dose levels. Compared with E2-induced growth at 10(-10) M, pregnane and 19-nortestosterone derived progestagens at 10(-6) M alone did enhance cell growth in T47D-A cells up to 25 and 100% respectively, whereas in T47D-S cells they did not influence growth. All these progestagens at 10(-6) M did not affect E2-induced growth in T47D-A cells, whereas in T47D-S cells they completely reduced cell proliferation at doses between 10(-10) and 10(-8) M. The involvement of progestagen (PR) and estrogen (ER) receptors with respect to growth stimulation was studied by using specific antihormones. In T47D-A cells, the antiprogestagens RU 38486 and Org 31710 could not block progestagen-induced growth. Antiestrogens, like 4-hydroxytamoxifen and ICI 164,384, inhibited the 19-nortestosterone derivative-induced cell growth by approx. 50%. Remarkably, both antiprogestagens alone could also inhibit E2-induced growth in T47D-A cells by about 50%. In T47D-S cells, E2-induced cell growth was completely blocked by both antiprogestagens and antiestrogens. Both antiprogestagens in T47D-S cells were equipotent to 4-hydroxytamoxifen and 10-fold more potent than ICI 164,384. In conclusion pregnane and 19-nortestosterone-derived progestagens stimulated cell growth in T47D-A cells at high unphysiological concentrations, whereas they did not affect cell growth in T47D-S cells. The 19-nortestosterone derivative induced growth in T47D-A cells could partially be inhibited by antiestrogens. In T47D-A cells, E2-induced cell growth was not influenced by both classes of progestagens, whereas in T47D-S cells all tested progestagens, antiprogestagens, and antiestrogens inhibited E2-induced cell growth completely. These results with T47D cells as well as those obtained previously with MCF-7 cells show that subclones of cell lines may respond differently to various types of progestagens in the presence and absence of estrogens.

Publication types

  • Comparative Study

MeSH terms

  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology*
  • Carcinoma / pathology
  • Cell Division / drug effects
  • Desogestrel / pharmacology
  • Dose-Response Relationship, Drug
  • Estradiol / pharmacology
  • Estrenes / pharmacology
  • Estrogen Antagonists / pharmacology
  • Female
  • Furans / pharmacology
  • Humans
  • Levonorgestrel / pharmacology
  • Medroxyprogesterone Acetate / pharmacology
  • Mifepristone / pharmacology
  • Nandrolone / analogs & derivatives*
  • Nandrolone / antagonists & inhibitors
  • Nandrolone / pharmacology*
  • Norethindrone / analogs & derivatives
  • Norethindrone / pharmacology
  • Norpregnenes / pharmacology
  • Pregnanes / antagonists & inhibitors
  • Pregnanes / pharmacology*
  • Pregnenediones / pharmacology
  • Progesterone / pharmacology
  • Promegestone / pharmacology
  • Tumor Cells, Cultured

Substances

  • Estrenes
  • Estrogen Antagonists
  • Furans
  • Norpregnenes
  • Pregnanes
  • Pregnenediones
  • Org 31710
  • Gestodene
  • 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione
  • etonogestrel
  • Mifepristone
  • Progesterone
  • Estradiol
  • Levonorgestrel
  • Nandrolone
  • Desogestrel
  • Promegestone
  • Medroxyprogesterone Acetate
  • Norethindrone
  • Org 30659